mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.02 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.02 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.02 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.02 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.02 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |